Introduction
iPSCs (Induced Pluripotent Stem Cells) are versatile cells reprogrammed from somatic cells to have similar differentiation potential as embryonic stem cells. With Allele's Clinical Grade iPSC Banking, you can securely store your cells under FDA-approved and cGMP-compliant conditions. These iPSCs can then be transformed into a variety of cell types, like nerve cells, cardiomyocytes, liver cells, pancreatic beta cells, and natural killer cells, to treat conditions such as Parkinson’s, heart disease, diabetes, cancer, and more.
By banking your iPSCs, you gain the advantage of precise therapies and proactive health management. Take the step today to invest in a healthier, secure future for yourself!
Features / strengths
- cGMP iPSC Cell Line Development for Precision Medicine
- Adopted by Global Biotech Companies and Renowned Medical Institutions
- Highest International cGMP Standards with Strict Quality Control
- FDA Approved, Suitable for Clinical and Commercial Phase III Applications
- AABB accredited
- cGMP iPSC Quality Control (QC) Testing
- Provide Various Cell Differentiation Services: MSCs, Hepatocytes, Pancreatic Beta Cells, and Natural Killer Cells
- Patented mRNA Reprogramming Technology
Specification in detail
Regulatory Standard
cGMP (current Good Manufacturing Practice)
Safety
FDA Approved, AABB accredited
